AtriCure
ATRC
233 hedge funds and large institutions have $1.7B invested in AtriCure in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 102 increasing their positions, 70 reducing their positions, and 33 closing their positions.
5,314% more call options, than puts
Call options by funds: $3.46M | Put options by funds: $64K
46% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 70
21% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 33
4.75% more ownership
Funds ownership: 95.85% → 100.6% (+4.8%)
1% more funds holding
Funds holding: 230 → 233 (+3)
14% less capital invested
Capital invested by funds: $1.99B → $1.7B (-$287M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$27.4M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$9.44M |
| 3 |
BlackRock
New York
|
+$8.75M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$8.61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$17.3M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$13.7M |
| 3 |
FAM
Fred Alger Management
New York
|
-$10.5M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.4M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$5.84M |
ATRC Hedge Fund Activity: Q4 2023 in Review
233 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2023, worth a combined $1.7B — down 14% from $1.99B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ATRC positions and 33 closed out — a net gain of 7 holders — while 102 added to existing stakes and 70 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $27.4M. The largest seller was Granite Investment Partners, exiting entirely with an estimated $17.3M sold.
- 233 institutional investors held AtriCure (ATRC) as of Q4 2023, up from 230 in Q3 2023.
- Funds reported $1.7B of AtriCure stock for Q4 2023, down 14% quarter-over-quarter.
- 40 funds opened new AtriCure positions in Q4 2023 and 33 closed out, a net change of +7 holders.
- The largest AtriCure buyer in Q4 2023 was Morgan Stanley, an estimated $27.4M added.
- The largest AtriCure seller in Q4 2023 was Granite Investment Partners, an estimated $17.3M sold.
Based on aggregated 13F filings for Q4 2023.